ETHYL 8-BROMOIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE, 95.0%, 10g

((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate, 98.0%, 25g

(2E)-3-(2-chloro-6-fluorophenyl)-1-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 2g

Diethyl 5-amino-1H-pyrrole-2,4-dicarboxylate, 95.0%, 100mg

N,N-Bis(4'-diphenylamino-4-biphenylyl)amine>95.0%(HPLC)(N)1g

2-tert-Butyl-6-(3-tert-butyl-2-hydroxy-5-methylbenzyl)-4-methylphenyl Acrylate>96.0%(HPLC)25g

3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine, 97%, 250mg

4-(1-Pyrrolidinyl)piperidine, 98.0%, 25g

N-Benzylethanolamine>95.0%(GC)(T)500mL

Phthaloyl-L-glutamic acid anhydride, 99.0%, 5g

RKI-1447, 95.0%, 100mg

3-(Pyrimidin-5-yl)propanoic acid, 95.0%, 2g

N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95.0%, 5g